GSDMD inhibitor GI-Y1 alleviates doxorubicin-induced cardiotoxicity via the inhibition of mitochondrial dysfunction

Toxicology and Applied Pharmacology 2026

View at publisher
Authors: Yucong Zhang, Ruihan Zheng, Minne Xie, Yunxuan Chen, Binbin Xia, Zexin Yang, Zhuoning Li, Yuzheng Li, Li Luo, Weijian Huang, Shanshan Dai, Bozhi Ye
+1 more Wenli Zhang
DOI: 10.1016/j.taap.2026.117713
Cited by: 2
References: 36

Fields of Study & Subjects

Inflammasome and immune disorders Chemotherapy-induced cardiotoxicity and mitigation Mitochondrial Function and Pathology

Publication details

Journal / source
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Volume
507
Pages
117713–117713
Publication date
10 January 2026
Language
EN